Retatrutide
Also called LY3437943
An experimental once-a-week "triple agonist" (GLP-1, GIP and glucagon) for weight loss.
- Usual amount
- 2–12 mg commonly reported
- How it’s taken
- Injection under the skin
- Half-life
- about 6 days half of it gone after
- Good after mixing
- 28 days in the fridge
Track this in StackbaseFree. Your doses, streaks and supplies in one private place.
What it is
Retatrutide acts on three hormone receptors at once. In a 48-week phase 2 trial, people on 12 mg a week lost about 24% of their body weight on average. It is still in phase 3 trials and is not approved anywhere.
How it’s used
- Injected under the skin once a week, with slow dose increases.
Typical amounts
- The phase 2 trial started most people at 2 mg a week and raised the dose over several weeks, up to 12 mg.
Good to know
- Not approved; anything sold now is unregulated.
- Side effects are like other GLP-1 drugs: nausea, diarrhea, vomiting, and a faster heart rate.
- Fast weight loss can cost muscle. Eat enough protein and strength train.
Educational information, not medical advice. Check anything you take with a doctor or pharmacist.